Feline Hyperthyroidism: Radioiodine Treatment and Welfare Outcomes

Radioiodine therapy is the gold standard treatment for feline hyperthyroidism, offering a permanent cure with minimal side effects when managed appropriately.

Key Facts

Feline hyperthyroidism is the most common endocrine disorder in cats over 10 years, affecting approximately 10% of older cats.
It is caused by benign thyroid adenoma or adenomatous hyperplasia producing excess thyroxine.
Clinical signs include weight loss despite increased appetite, hyperactivity, vomiting, and unkempt coat.
Untreated hyperthyroidism causes cardiac hypertrophy, hypertension, and progressive organ damage.
Radioiodine (I-131) destroys overactive thyroid tissue with a single subcutaneous injection.
Cure rates with radioiodine exceed 95% with a single treatment.
Treated cats require isolation for 1-3 weeks as they emit residual radiation in urine and faeces.
After successful treatment, some cats develop post-treatment hypothyroidism requiring monitoring.

Welfare Considerations

Hyperthyroidism causes chronic suffering that owners often misinterpret as normal aging: weight loss, anxiety, hypertension-related vision changes, and cardiac stress. Untreated cats deteriorate progressively over months to years. The isolation period required after radioiodine treatment is a welfare consideration — cats must be hospitalised without owner contact for 1-3 weeks, which is distressing for socially bonded individuals. Facilities that provide enrichment, regular quiet keeper contact, and comfortable housing during isolation significantly reduce this welfare cost. Post-treatment hypothyroidism, if undetected, can cause its own set of welfare problems. The permanent cure radioiodine offers far outweighs the temporary isolation stress for most cats.

What You Can Do

Have older cats screened for hyperthyroidism annually from age 10 — early detection prevents organ damage.
Discuss radioiodine as the preferred treatment option with your vet — it is curative rather than managing symptoms.
Choose a radioiodine facility that provides enriched, comfortable housing during the mandatory isolation period.
Monitor kidney function before and after treatment — hyperthyroidism can mask concurrent kidney disease.
Follow up with thyroid level testing at 1 and 6 months post-treatment to detect hypothyroidism.
Understand that the isolation period, while difficult, leads to a permanent cure and improved quality of life.